Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer

Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer

Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early stage breast cancer would result in equivalent surv...

Descrición completa

Detalles Bibliográficos
Main Authors: Jaime D. Lewis, Anees B. Chagpar, Elizabeth A. Shaughnessy, Jacob Nurko, Kelly McMasters, Michael J. Edwards
Formato: Artigo
Idioma:Russian
Publicado: ABV-press 2014-11-01
Series:Опухоли женской репродуктивной системы
Subjects:
toremifene
tamoxifen
breast cancer
selective estrogen-receptor modulator
survival
Acceso en liña:https://ojrs.abvpress.ru/ojrs/article/view/390

Títulos similares

Títulos similares